Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report

A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.

Bibliographic Details
Main Authors: Rafael Paolo Lansang, Irene X Zhao, Perla Lansang
Format: Article
Language:English
Published: SAGE Publishing 2023-06-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X231180766
_version_ 1797804140114477056
author Rafael Paolo Lansang
Irene X Zhao
Perla Lansang
author_facet Rafael Paolo Lansang
Irene X Zhao
Perla Lansang
author_sort Rafael Paolo Lansang
collection DOAJ
description A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.
first_indexed 2024-03-13T05:32:40Z
format Article
id doaj.art-830b213bd2d04ae39f8ed559394346c1
institution Directory Open Access Journal
issn 2050-313X
language English
last_indexed 2024-03-13T05:32:40Z
publishDate 2023-06-01
publisher SAGE Publishing
record_format Article
series SAGE Open Medical Case Reports
spelling doaj.art-830b213bd2d04ae39f8ed559394346c12023-06-14T17:03:43ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2023-06-011110.1177/2050313X231180766Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case reportRafael Paolo Lansang0Irene X Zhao1Perla Lansang2Michael G. Degroote School of Medicine, McMaster University, Hamilton, ON, CanadaMichael G. Degroote School of Medicine, McMaster University, Hamilton, ON, CanadaDivision of Dermatology, University of Toronto, Toronto, ON, CanadaA patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.https://doi.org/10.1177/2050313X231180766
spellingShingle Rafael Paolo Lansang
Irene X Zhao
Perla Lansang
Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
SAGE Open Medical Case Reports
title Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_full Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_fullStr Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_full_unstemmed Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_short Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_sort atopic dermatitis treated with tralokinumab and upadacitinib combination therapy a case report
url https://doi.org/10.1177/2050313X231180766
work_keys_str_mv AT rafaelpaololansang atopicdermatitistreatedwithtralokinumabandupadacitinibcombinationtherapyacasereport
AT irenexzhao atopicdermatitistreatedwithtralokinumabandupadacitinibcombinationtherapyacasereport
AT perlalansang atopicdermatitistreatedwithtralokinumabandupadacitinibcombinationtherapyacasereport